These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25304009)

  • 1. Use of administrative hospital database to identify adverse drug reactions in a Pediatric University Hospital.
    Durrieu G; Batz A; Rousseau V; Bondon-Guitton E; Petiot D; Montastruc JL
    Eur J Clin Pharmacol; 2014 Dec; 70(12):1519-26. PubMed ID: 25304009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital databases for the identification of adverse drug reactions: A 2-year multicentre study in 9 French general hospitals.
    Osmont MN; Degremont A; Jantzem H; Audouard-Marzin Y; Lalanne S; Carlhant-Kowalski D; Bellissant E; Oger E; Polard E
    Br J Clin Pharmacol; 2021 Feb; 87(2):471-482. PubMed ID: 32484575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital].
    Montastruc JL; Lugardon S; Desboeuf K; Fernet P; Lapeyre-Mestre M
    Bull Acad Natl Med; 2008 Feb; 192(2):421-30; discussion 430-1. PubMed ID: 18819693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
    Lugardon S; Desboeuf K; Fernet P; Montastruc JL; Lapeyre-Mestre M
    Br J Clin Pharmacol; 2006 Aug; 62(2):225-31. PubMed ID: 16842398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of the PMSI for the detection of adverse drug reactions].
    Osmont MN; Cuggia M; Polard E; Riou C; Balusson F; Oger E
    Therapie; 2013; 68(4):285-95. PubMed ID: 23981266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and Nature of Adverse Drug Reactions Due to Non-Prescription Drugs in Children: A Retrospective Analysis from the French Pharmacovigilance Database.
    Durrieu G; Maupiler M; Rousseau V; Chebane L; Montastruc F; Bondon-Guitton E; Montastruc JL
    Paediatr Drugs; 2018 Feb; 20(1):81-87. PubMed ID: 28766184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive predictive values of selected hospital discharge diagnoses to identify infections responsible for hospitalization in the French national hospital database.
    Sahli L; Lapeyre-Mestre M; Derumeaux H; Moulis G
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):785-9. PubMed ID: 27125251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical adverse drug reactions: descriptive analysis of French reports.
    Hakimi Y; Petitpain N; Pinzani V; Montastruc JL; Bagheri H
    Eur J Clin Pharmacol; 2020 Aug; 76(8):1169-1174. PubMed ID: 32418024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender differences in adverse drug reactions: analysis of spontaneous reports to a Regional Pharmacovigilance Centre in France.
    Montastruc JL; Lapeyre-Mestre M; Bagheri H; Fooladi A
    Fundam Clin Pharmacol; 2002 Oct; 16(5):343-6. PubMed ID: 12608357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving adverse drug reaction reporting in hospitals: results of the French Pharmacovigilance in Midi-Pyrénées region (PharmacoMIP) network 2-year pilot study.
    Gony M; Badie K; Sommet A; Jacquot J; Baudrin D; Gauthier P; Montastruc JL; Bagheri H
    Drug Saf; 2010 May; 33(5):409-16. PubMed ID: 20397740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacovigilance in children in Camagüey Province, Cuba.
    Bárzaga Arencibia Z; López Leyva A; Mejías Peña Y; González Reyes AR; Fernández Manzano E; Choonara I
    Eur J Clin Pharmacol; 2012 Jul; 68(7):1079-84. PubMed ID: 22315149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001).
    Thiessard F; Roux E; Miremont-Salamé G; Fourrier-Réglat A; Haramburu F; Tubert-Bitter P; Bégaud B
    Drug Saf; 2005; 28(8):731-40. PubMed ID: 16048358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adverse effects of anticancer drugs: apropos of a pharmacovigilance study at a specialized oncology institution].
    Couffignal AL; Lapeyre-Mestre M; Bonhomme C; Bugat R; Montastruc JL
    Therapie; 2000; 55(5):635-41. PubMed ID: 11201979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced adverse reactions via breastfeeding: a descriptive study in the French Pharmacovigilance Database.
    Soussan C; Gouraud A; Portolan G; Jean-Pastor MJ; Pecriaux C; Montastruc JL; Damase-Michel C; Lacroix I
    Eur J Clin Pharmacol; 2014 Nov; 70(11):1361-6. PubMed ID: 25183382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary).
    Tavassoli N; Sommet A; Lapeyre-Mestre M; Bagheri H; Montrastruc JL
    Drug Saf; 2007; 30(11):1063-71. PubMed ID: 17973542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentially inappropriate medications and adverse drug reactions in the elderly: a study in a PharmacoVigilance database.
    Montastruc F; Duguet C; Rousseau V; Bagheri H; Montastruc JL
    Eur J Clin Pharmacol; 2014 Sep; 70(9):1123-7. PubMed ID: 24925091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive predictive values of peripheral arterial and venous thrombosis codes in French hospital database.
    Prat M; Derumeaux H; Sailler L; Lapeyre-Mestre M; Moulis G
    Fundam Clin Pharmacol; 2018 Feb; 32(1):108-113. PubMed ID: 29055145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevacizumab-induced serious side-effects: a review of the French pharmacovigilance database.
    Taugourdeau-Raymond S; Rouby F; Default A; Jean-Pastor MJ;
    Eur J Clin Pharmacol; 2012 Jul; 68(7):1103-7. PubMed ID: 22349162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of adverse drug reactions using hospital databases-a nationwide study in Portugal.
    Miguel A; Bernardo Marques ; Freitas A; Lopes F; Azevedo L; Pereira AC
    Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):907-13. PubMed ID: 23761351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.
    Durrieu G; Palmaro A; Pourcel L; Caillet C; Faucher A; Jacquet A; Ouaret S; Perault-Pochat MC; Kreft-Jais C; Castot A; Lapeyre-Mestre M; Montastruc JL;
    Drug Saf; 2012 Oct; 35(10):845-54. PubMed ID: 22967189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.